Alba Toll

Alba Toll

Auto-generated profile, based on publicly available information

Alba Toll

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2022 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
ASAna M. Sánchez-Torres
Ana M. Sánchez-Torres
SASilvia Amoretti
Silvia Amoretti
MGMónica Enguita Germán
Mónica Enguita Germán
GMGisela Mezquida
Gisela Mezquida
LMLucía Moreno-Izco
Lucía Moreno-Izco
LGLeticia González-Blanco
Leticia González-Blanco

26 March 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
VOVincenzo Oliva
Vincenzo Oliva
NRNatalia Roberto
Natalia Roberto
JAJorge Andreo
Jorge Andreo
Teresa Bobes-BascaránTeresa Bobes-Bascarán
Teresa Bobes-Bascarán
MCManuel Canal-Rivero
Manuel Canal-Rivero
VPVíctor Pérez-Solà
Víctor Pérez-Solà

1 January 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YSYolanda Sánchez‐Carro
Yolanda Sánchez‐Carro
MPMaria J. Portella
Maria J. Portella
ILItziar Leal-Leturia
Itziar Leal-Leturia
NSNeus Salvat‐Pujol
Neus Salvat‐Pujol
MEMikel Etxandi
Mikel Etxandi
PLPilar López-García
Pilar López-García

9 June 2022 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
ASAlex G. Segura
Alex G. Segura
GMGisela Mezquida Mateos
Gisela Mezquida Mateos
AMAlbert Martínez-Pinteño
Albert Martínez-Pinteño
PGPatricia Gasso
Patricia Gasso
NRNatalia Rodriguez
Natalia Rodriguez
PGPEPs Group
PEPs Group
Background: Clinical intervention in early stages of psychotic disorders is crucial for the prevention of severe symptomatology trajectories and poor outcomes. Genetic variability is studied as a promising modulator of prognosis, thus novel approaches considering the polygenic nature of these complex phenotypes are required to unravel the mechanisms underlying the early progression of the disorder.Methods: The sample comprised of 233 first-episode psychosis (FEP) subjects with clinical and cognitive data assessed periodically for a 2-year period and 150 matched controls. Polygenic risk scores (PRSs) for schizophrenia, bipolar disorder, depression, education attainment and cognitive performance were used to assess the genetic risk of FEP and to characterize their association with premorbid, baseline and progression of clinical and cognitive status.Results: Schizophrenia, bipolar disorder and cognitive performance PRSs were associated with an increased risk of FEP [false discovery rate (FDR) ⩽ 0.027]. In FEP patients, increased cognitive PRSs were found for FEP patients with more cognitive reserve (FDR ⩽ 0.037). PRSs reflecting a genetic liability for improved cognition were associated with a better course of symptoms, functionality and working memory (FDR ⩽ 0.039). Moreover, the PRS of depression was associated with a worse trajectory of the executive function and the general cognitive status (FDR ⩽ 0.001).Conclusions: Our study provides novel evidence of the polygenic bases of psychosis and its clinical manifestation in its first stage. The consistent effect of cognitive PRSs on the early clinical progression suggests that the mechanisms underlying the psychotic episode and its severity could be partially independent.

28 April 2023 in Psychiatry Research
Verified
Journal Article
Closed access
ATAlba Toll
Alba Toll
EPEmilio Pechuan
Emilio Pechuan
DBDaniel Bergé
Daniel Bergé
TLTeresa Legido
Teresa Legido
LMLaura Martínez-Sadurní
Laura Martínez-Sadurní
AMAnna Mané
Anna Mané

27 January 2023 in European Neuropsychopharmacology
Verified
Journal Article
Open access
ATAlba Toll
Alba Toll
LBLaura Blanco-Hinojo
Laura Blanco-Hinojo
DBDaniel Berge
Daniel Berge
MMMarta Martín-Subero
Marta Martín-Subero
FCFrancesc Casanovas
Francesc Casanovas
AMAnna Mané
Anna Mané
Circulating white blood cells (leucocytes), which form the peripheral immune system, are crucial in inflammatory processes but their role in brain structural change in schizophrenia has been scarcely studied. With this study we want to determine how and which type of white blood cells are associated with hippocampal volume (as a key structure in schi- zophrenia etiopathology) in first episode psychosis (FEP) patients. Moreover, to determine the association between white blood cells and clinical symptomatology, including positive and negative symptoms, cognition and depression. For this purpose fifty drug-naïve FEP were included in this study. All patients underwent an assessment at baseline and at 1 year follow-up, including sociodemographic and clinical variables (substance use, DUP, PANSS, GAF and CDSS). Fasting blood samples were obtained before administering any medication at baseline. Structural T1 MRI was performed at baseline and brain volumes were quantified. In the present study, higher lymphocyte count was associated with larger right hippocampal volume at baseline in FEP drug-naive patients. Higher lymphocyte count was associated with lower depressive symptomatology measured with CDSS and Marder depressive factor from PANSS at baseline and 1-year follow -up. These results suggest that lymphocytes may have a protective effect in hippocampal volume at baseli- ne in antipsychotic naïve FEP and also, are associated with a better depressive course over follow up. These results open the door to identify new biomarkers and therapeutic targets for patients with schizophrenia.